Rebecca A Miksad Kuan-Chi Lai Marion C Stein Megan E Healy Rafael Rojas Katherine M Krajewski Andrew X Zhu
10.1007/s12029-009-9086-7
J Gastrointest Cancer
2009;40(3-4):119-22.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/19894033/
Antineoplastic Agents / adverse effects Carcinoma, Hepatocellular / drug therapy Gait Disorders, Neurologic / chemically induced Indoles / adverse effects Liver Neoplasms / drug therapy Postural Balance / drug effects Pyrroles / adverse effects
Antineoplastic Agents / adverse effects Carcinoma, Hepatocellular / drug therapy Gait Disorders, Neurologic / chemically induced Indoles / adverse effects Liver Neoplasms / drug therapy Postural Balance / drug effects Pyrroles / adverse effects Case Reports Aged Carcinoma, Hepatocellular / complications Clinical Trials, Phase III as Topic Gait Disorders, Neurologic / physiopathology Hepatitis, Autoimmune / complications Humans Liver Neoplasms / complications Male Protein Kinase Inhibitors / adverse effects Protein-Tyrosine Kinases / antagonists & inhibitors Protein-Tyrosine Kinases / drug effects Sensation Disorders / chemically induced Sunitinib Antineoplastic Agents Indoles Protein Kinase Inhibitors Pyrroles Protein-Tyrosine Kinases Sunitinib
PMC3417813
19894033
Imbalance and gait disturbance from tyrosine kinase inhibition in hepatocellular cancer
2009